Erschienen in:
02.08.2021 | Letter to the Editor
Prediction of treatment response in patients with locally advanced cervical cancer using midtreatment PET/MRI during concurrent chemoradiotherapy. In regard to Vojtíšek et al.
verfasst von:
Cem Onal, Guler Yavas, Cagdas Yavas
Erschienen in:
Strahlentherapie und Onkologie
|
Ausgabe 10/2021
Einloggen, um Zugang zu erhalten
Excerpt
We read the article by Vojtíšek et al. [
1] with great interest and commend all authors for demonstrating the feasibility of midtreatment metabolic parameters measured with positron-emission tomography/magnetic resonance imaging (PET/MRI) in 66 patients with locally advanced cervical cancer undergoing concurrent chemoradiotherapy (ChRT). Although the authors demonstrated that metabolic parameters could be used to distinguish patients with incomplete responses, a few points need to be clarified. …